GeneDx (WGS) Short Interest Ratio & Short Volume → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free WGS Stock Alerts $21.16 -0.19 (-0.89%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GeneDx Short Interest DataCurrent Short Volume1,160,000 sharesPrevious Short Volume1,070,000 sharesChange Vs. Previous Month+8.41%Dollar Volume Sold Short$19.80 millionShort Interest Ratio / Days to Cover3.0Last Record DateApril 30, 2024Outstanding Shares26,120,000 sharesFloat Size16,270,000 sharesShort Percent of Float7.13%Today's Trading Volume437,987 sharesAverage Trading Volume389,662 sharesToday's Volume Vs. Average112% Short Selling GeneDx ? Sign up to receive the latest short interest report for GeneDx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatWGS Short Interest Over TimeWGS Days to Cover Over TimeWGS Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… GeneDx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,160,000 shares $19.80 million +8.4%7.1%3 $17.07 4/15/20241,070,000 shares $10.57 million -2.7%6.6%5 $9.88 3/31/20241,100,000 shares $10.04 million +4.8%6.8%4.2 $9.13 3/15/20241,050,000 shares $12.61 million -4.6%6.5%3.8 $12.01 2/29/20241,100,000 shares $8.97 million -9.1%6.8%3.7 $8.15 2/15/20241,210,000 shares $5.38 million +14.2%7.5%3.1 $4.45 Get the Latest News and Ratings for WGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,060,000 shares $4.08 million +6.9%6.9%2.7 $3.85 1/15/2024991,900 shares $3.63 million +44.7%6.4%2.5 $3.66 12/31/2023685,700 shares $1.89 million +9.4%4.4%2 $2.75 12/15/2023626,600 shares $1.52 million -16.5%4.0%2 $2.43 11/30/2023750,100 shares $1.31 million +15.2%4.8%2.8 $1.75 11/15/2023651,400 shares $840,306.00 -16.4%4.2%2.9 $1.29 10/31/2023779,100 shares $1.45 million +1.7%5.0%8.5 $1.86 10/15/2023765,900 shares $2.47 million +8.7%4.9%10.2 $3.23 9/30/2023704,500 shares $2.56 million -2.7%4.5%9.6 $3.64 9/15/2023724,300 shares $3.17 million +2.6%4.7%7.8 $4.38 8/31/2023705,700 shares $3.14 million +1.4%4.2%5.4 $4.45 8/15/2023696,200 shares $3.57 million -2.3%4.2%4.3 $5.13 7/31/2023712,600 shares $5.28 million -0.8%4.3%4.1 $7.41 7/15/2023718,200 shares $4.83 million -6.9%4.3%3.9 $6.72 6/30/2023771,500 shares $4.60 million -18.7%4.6%4.4 $5.96 6/15/2023949,200 shares $6.95 million +18.8%5.7%5.8 $7.32 5/31/2023798,700 shares $6.01 million +7.8%4.9%5.1 $7.52 5/15/2023740,800 shares $5.32 million No Change4.6%5.6 $7.18 12/15/20224,770,000 shares $1.34 million -25.2%2.8%2.8 $0.28 11/30/20226,380,000 shares $2.64 million -35.9%3.9%4.5 $0.41 11/15/20229,950,000 shares $8.76 million -8.1%6.0%9.6 $0.88 10/31/202210,830,000 shares $11.15 million -1.5%6.7%8.8 $1.03 10/15/202210,990,000 shares $9.42 million -4.0%6.8%8.8 $0.86 9/30/202211,450,000 shares $10.05 million +1.2%7.0%8.7 $0.88 9/15/202211,320,000 shares $11.32 million -5.0%7.0%6.3 $1.00 8/31/202211,920,000 shares $12.16 million -1.2%7.4%5.6 $1.02 8/15/202212,060,000 shares $28.94 million -19.8%7.5%5.3 $2.40 7/31/202215,030,000 shares $24.35 million +10.3%9.4%6.9 $1.62 7/15/202213,630,000 shares $21.54 million +9.9%8.5%5.8 $1.58 6/30/202212,400,000 shares $15.62 million +18.3%7.7%5.3 $1.26 6/15/202210,480,000 shares $15.20 million +11.4%6.5%4.6 $1.45 5/31/20229,410,000 shares $19.20 million +22.7%5.9%5.3 $2.04 5/15/20227,670,000 shares $15.72 million +61.8%4.8%4.8 $2.05 4/30/20224,740,000 shares $10.19 million -1.9%4.0%3.3 $2.15Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic WGS Short Interest - Frequently Asked Questions What is GeneDx's current short interest? Short interest is the volume of GeneDx shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,160,000 shares of WGS short. 7.13% of GeneDx's shares are currently sold short. Learn More on GeneDx's current short interest. What is a good short interest ratio for GeneDx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WGS shares currently have a short interest ratio of 3.0. Learn More on GeneDx's short interest ratio. What is a good short interest percentage for GeneDx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.13% of GeneDx's floating shares are currently sold short. Is GeneDx's short interest increasing or decreasing? GeneDx saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,160,000 shares, an increase of 8.4% from the previous total of 1,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GeneDx's float size? GeneDx currently has issued a total of 26,120,000 shares. Some of GeneDx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GeneDx currently has a public float of 16,270,000 shares. How does GeneDx's short interest compare to its competitors? 7.13% of GeneDx's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to GeneDx: InnovAge Holding Corp. (1.73%), Talkspace, Inc. (3.02%), The Pennant Group, Inc. (0.96%), DocGo Inc. (10.25%), Sharecare, Inc. (5.44%), P3 Health Partners Inc. (5.58%), U.S. Physical Therapy, Inc. (4.69%), Privia Health Group, Inc. (5.75%), Valneva SE (0.08%), SIGA Technologies, Inc. (13.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short GeneDx stock? Short selling WGS is an investing strategy that aims to generate trading profit from GeneDx as its price is falling. WGS shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GeneDx? A short squeeze for GeneDx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WGS, which in turn drives the price of the stock up even further. How often is GeneDx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WGS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: INNV Short Interest TALK Short Interest PNTG Short Interest DCGO Short Interest SHCR Short Interest PIII Short Interest USPH Short Interest PRVA Short Interest VALN Short Interest SIGA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WGS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts